Company Profile
Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company provides the research and development of drugs in China. The company operates external preparation platform that focuses on the R&D of new drugs and generic drugs for skin external preparations.
Its portfolio also includes children's clinical data bridging research center, pediatric drug R&D platform, pediatric drug delivery dosage R&D platform, respiratory tract drug delivery and topical preparation platforms, polypeptide and drug molecular design and development platform, genotoxic impurity detection platform, technology platform for slow and controlled release preparations, drug synthesis platform, and synthesis technology platform
SMO, clinical quality management, data management and statistical analysis, project management, test center, clinical research center, clinical trials, TMFDocument management, quality control, Medical Writing, medical monitoring, and pharmacovigilance services
Registration-related services for chemical drugs, biological products, and medical device products. Additionally, it operates quantitative pharmacology platform that use technology on pharmacokinetics, pharmacodynamics, body function, disease mechanism and test process, and information for quantitative research
Mass spectrometry, immunological analysis, cell biology, and molecular biology platforms that provide biological analysis services for large and small molecular drugs Operates as a Contract Research Organization for Professional Peptide Drug R&D. The company offers clinical research technology services to pharmaceutical companies and new drug research institutions. Founded in 2009, Beijing Sun-Novo Pharmaceutical Research is based in Beijing, China.